Related Experiment Video
Updated: Jul 4, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
Beyond Oral Therapies: A Practical Approach to Overcoming Barriers to Intracavernosal Injection Therapy in Clinical
Lucas Vasconcelos Sanvido1, Nilson Marquardt1, Thiago Afonso Teixeira2,3,4
1Departamento de Cirurgia, Divisão de Urologia, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo - HC-FMUSP, São Paulo, SP, Brasil.
Intracavernous injection (ICI) therapy offers a safe and effective second-line treatment for erectile dysfunction (ED) when first-line options fail. This guide provides a strategy for physicians to optimize ICI implementation, ensuring patient safety and treatment success.
Area of Science:
- Urology
- Andrology
- Sexual Medicine
Background:
- Phosphodiesterase type 5 inhibitors (PDE5i) are first-line for erectile dysfunction (ED), but approximately one-third of patients have unsatisfactory outcomes.
- Intracavernous injection (ICI) therapy is a highly effective second-line treatment option for ED.
Purpose of the Study:
- To present intracavernous therapy as a model and guide for physicians introducing and managing it in patients with ED.
- To propose a strategy for safe and effective implementation of ICI therapy, minimizing complications and enhancing patient adherence.
Main Methods:
- Comprehensive review detailing patient selection criteria for ICI therapy.
- Guidelines on drug formulation, structured patient education, and stepwise dose titration.
- Strategies for managing adverse events and ensuring longitudinal follow-up for optimal outcomes.
Main Results:
- A standardized approach to ICI therapy can minimize treatment-related complications.
- Enhanced patient confidence and adherence are achievable through structured education and follow-up.
- Optimized implementation of ICI therapy can overcome barriers to its broader clinical adoption.
Conclusions:
- ICI therapy is a crucial second-line option for managing ED, offering high efficacy.
- A systematic approach to patient selection, education, and management is essential for successful ICI therapy.
- Standardizing ICI therapy implementation can improve patient outcomes and increase its use in clinical practice.
Related Concept Videos
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
Routes of Drug Administration: Parenteral
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
Oral Drug Delivery Systems: Introduction
Additional Routes of Drug Administration
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...

